TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Bio-Gene Technology Ltd. ( (AU:BGT) ).
Bio-Gene Technology Limited has released its corporate governance statement for the financial year ending June 30, 2025, in compliance with ASX Listing Rules. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, indicating a commitment to transparency and accountability in its operations. This disclosure is expected to reinforce stakeholder confidence and support Bio-Gene’s strategic positioning in the biotechnology sector.
More about Bio-Gene Technology Ltd.
Bio-Gene Technology Limited operates in the biotechnology industry, focusing on the development of novel insecticides. The company aims to address the global need for new and effective pest control solutions, targeting both agricultural and public health markets.
Average Trading Volume: 242,325
Technical Sentiment Signal: Sell
Current Market Cap: A$6.41M
Find detailed analytics on BGT stock on TipRanks’ Stock Analysis page.

